These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Synthesis and Structure-Activity Relationships of Tetrahydro-β-carboline Derivatives as Anticancer and Cancer-chemopreventive Agents. Zhang M; Park EJ; Kondratyuk TP; Pezzuto JM; Sun D Anticancer Res; 2018 Aug; 38(8):4425-4433. PubMed ID: 30061206 [TBL] [Abstract][Full Text] [Related]
5. Bicyclic derivatives of the potent dual aromatase-steroid sulfatase inhibitor 2-bromo-4-{[(4-cyanophenyl)(4h-1,2,4-triazol-4-yl)amino]methyl}phenylsulfamate: synthesis, SAR, crystal structure, and in vitro and in vivo activities. Wood PM; Woo LW; Labrosse JR; Thomas MP; Mahon MF; Chander SK; Purohit A; Reed MJ; Potter BV ChemMedChem; 2010 Sep; 5(9):1577-93. PubMed ID: 20632362 [TBL] [Abstract][Full Text] [Related]
6. Molecular docking and QSAR study on steroidal compounds as aromatase inhibitors. Dai Y; Wang Q; Zhang X; Jia S; Zheng H; Feng D; Yu P Eur J Med Chem; 2010 Dec; 45(12):5612-20. PubMed ID: 20926163 [TBL] [Abstract][Full Text] [Related]
7. Recent developments in steroidal and nonsteroidal aromatase inhibitors for the chemoprevention of estrogen-dependent breast cancer. Ahmad I; Shagufta Eur J Med Chem; 2015 Sep; 102():375-86. PubMed ID: 26301554 [TBL] [Abstract][Full Text] [Related]
8. Design, synthesis, and biological evaluation of resveratrol analogues as aromatase and quinone reductase 2 inhibitors for chemoprevention of cancer. Sun B; Hoshino J; Jermihov K; Marler L; Pezzuto JM; Mesecar AD; Cushman M Bioorg Med Chem; 2010 Jul; 18(14):5352-66. PubMed ID: 20558073 [TBL] [Abstract][Full Text] [Related]
9. Synthesis, Aromatase Inhibitory, Antiproliferative and Molecular Modeling Studies of Functionally Diverse D-Ring Pregnenolone Pyrazoles. Banday AH; Saeed BA; Al-Masoudi NA Anticancer Agents Med Chem; 2021; 21(13):1671-1679. PubMed ID: 33238853 [TBL] [Abstract][Full Text] [Related]
11. Structure-activity relationships and docking studies of synthetic 2-arylindole derivatives determined with aromatase and quinone reductase 1. Prior AM; Yu X; Park EJ; Kondratyuk TP; Lin Y; Pezzuto JM; Sun D Bioorg Med Chem Lett; 2017 Dec; 27(24):5393-5399. PubMed ID: 29153737 [TBL] [Abstract][Full Text] [Related]
12. Synthesis of aromatase inhibitors and dual aromatase steroid sulfatase inhibitors by linking an arylsulfamate motif to 4-(4H-1,2,4-triazol-4-ylamino)benzonitrile: SAR, crystal structures, in vitro and in vivo activities. Bubert C; Woo LW; Sutcliffe OB; Mahon MF; Chander SK; Purohit A; Reed MJ; Potter BV ChemMedChem; 2008 Nov; 3(11):1708-30. PubMed ID: 18816537 [TBL] [Abstract][Full Text] [Related]
13. Synthesis of novel 3,5-diaryl pyrazole derivatives using combinatorial chemistry as inhibitors of tyrosinase as well as potent anticancer, anti-inflammatory agents. Bandgar BP; Totre JV; Gawande SS; Khobragade CN; Warangkar SC; Kadam PD Bioorg Med Chem; 2010 Aug; 18(16):6149-55. PubMed ID: 20638287 [TBL] [Abstract][Full Text] [Related]
14. Synthesis and evaluation of 4-triazolylflavans as new aromatase inhibitors. Yahiaoui S; Pouget C; Fagnere C; Champavier Y; Habrioux G; Chulia AJ Bioorg Med Chem Lett; 2004 Oct; 14(20):5215-8. PubMed ID: 15380230 [TBL] [Abstract][Full Text] [Related]
15. Design and synthesis of N-phenylacetyl (sulfonyl) 4,5-dihydropyrazole derivatives as potential antitumor agents. Liu XH; Ruan BF; Liu JX; Song BA; Jing LH; Li J; Yang Y; Zhu HL; Qi XB Bioorg Med Chem Lett; 2011 May; 21(10):2916-20. PubMed ID: 21486698 [TBL] [Abstract][Full Text] [Related]
16. Synthesis and structure-activity relationships of novel 1-arylmethyl-3-aryl-1H-pyrazole-5-carbohydrazide hydrazone derivatives as potential agents against A549 lung cancer cells. Xia Y; Fan CD; Zhao BX; Zhao J; Shin DS; Miao JY Eur J Med Chem; 2008 Nov; 43(11):2347-53. PubMed ID: 18313806 [TBL] [Abstract][Full Text] [Related]
17. Synthesis and study of some new N-substituted imide derivatives as potential anticancer agents. Jindal DP; Bedi V; Jit B; Karkra N; Guleria S; Bansal R; Palusczak A; Hartmann RW Farmaco; 2005 Apr; 60(4):283-90. PubMed ID: 15848202 [TBL] [Abstract][Full Text] [Related]
18. Synthesis and aromatase inhibitory activity of some new 16E-arylidenosteroids. Bansal R; Thota S; Karkra N; Minu M; Zimmer C; Hartmann RW Bioorg Chem; 2012 Dec; 45():36-40. PubMed ID: 23064126 [TBL] [Abstract][Full Text] [Related]
19. Anti-inflammatory profile of some synthesized heterocyclic pyridone and pyridine derivatives fused with steroidal structure. Amr AG; Abdulla MM Bioorg Med Chem; 2006 Jul; 14(13):4341-52. PubMed ID: 16545570 [TBL] [Abstract][Full Text] [Related]